↓ Skip to main content

Dove Medical Press

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, April 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

policy
1 policy source
twitter
5 X users
facebook
2 Facebook pages

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
74 Mendeley
Title
Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
Published in
Pharmacogenomics and Personalized Medicine, April 2016
DOI 10.2147/pgpm.s84854
Pubmed ID
Authors

Adem Yesuf Dawed, Kaixin Zhou, Ewan Robert Pearson

Abstract

Type 2 diabetes is one of the leading causes of morbidity and mortality, consuming a significant proportion of public health spending. Oral hypoglycemic agents (OHAs) are the frontline treatment approaches after lifestyle changes. However, huge interindividual variation in response to OHAs results in unnecessary treatment failure. In addition to nongenetic factors, genetic factors are thought to contribute to much of such variability, highlighting the importance of the potential of pharmacogenetics to improve therapeutic outcome. Despite the presence of conflicting results, significant progress has been made in an effort to identify the genetic markers associated with pharmacokinetics, pharmacodynamics, and ultimately therapeutic response and/or adverse outcomes to OHAs. As such, this article presents a comprehensive review of current knowledge on pharmacogenetics of OHAs and provides insights into knowledge gaps and future directions.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 74 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 16%
Student > Bachelor 11 15%
Researcher 10 14%
Student > Ph. D. Student 7 9%
Other 5 7%
Other 10 14%
Unknown 19 26%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 15 20%
Medicine and Dentistry 13 18%
Pharmacology, Toxicology and Pharmaceutical Science 10 14%
Agricultural and Biological Sciences 5 7%
Nursing and Health Professions 2 3%
Other 8 11%
Unknown 21 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2019.
All research outputs
#5,269,238
of 25,748,735 outputs
Outputs from Pharmacogenomics and Personalized Medicine
#1
of 1 outputs
Outputs of similar age
#76,583
of 315,638 outputs
Outputs of similar age from Pharmacogenomics and Personalized Medicine
#1
of 1 outputs
Altmetric has tracked 25,748,735 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 315,638 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them